De-Risk SDD Scale-Up and Predict Performance Through 3D Microstructure Science

Microstructure CQAs
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network

Spray-Dried Dispersions (SDDs) offer a powerful path for poorly soluble APIs, but managing phase separation, morphology, and dissolution dynamics remains a constant challenge. Traditional empirical testing can delay scale-up and push back timelines by months. In this webinar, industry experts demonstrate how 3D imaging (CT/SEM) paired with physics-informed simulation transforms raw physical samples into quantifiable digital twins. You will learn how to map particle-level morphology, porosity, and spatial distribution directly to dissolution performance and process stability before committing to costly manufacturing or clinical scale-up.

AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Purple tablet dispersing into a fine particle cloud, illustrating drug microstructure disintegration